KSQ Therapeutics Appoints Chris Heberlig as Chief Financial Officer

As we continue to expand and progress our pipeline, his experience will be invaluable.\xe2\x80\x9d\n\xe2\x80\x9cIt is an exciting time to be joining KSQ,\xe2\x80\x9d said Mr. Heberlig.